Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Aplidine

EU orphan designation number: EU/3/03/151
Active ingredient: Aplidine
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: Pharma Mar S.A.
Avda de los Reyes 1, Polígono Industrial La Mina, E-28770 Colmenar Viejo, Madrid, España

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/07/2003 Centralised Orphan - Designation EMEA/OD/022/03 (2003)2578 of 09/07/2003
27/06/2011 Centralised Orphan - Removal of orphan designation from Community Register